A “Strong Buy” rating from Wall Street indicates that analysts believe a stock has the potential for future price ...

Listed below are links to the GEN stories reference in this episode of Touching Base Gene Therapy Tested in Mice Offers New ...

New research from the University of Colorado Anschutz Medical Campus is the first to identify defects related to metabolism (how the body processes and uses energy) in lymphoblast cell lines (LCLs) ...

New research from the University of Colorado Anschutz Medical Campus is the first to identify defects related to metabolism ...

The research, taking place at the Allen Institute for Brain Science, offers new hope to families fighting against Dravet Syndrome, a severe form of epilepsy that devastates childhood development.

Scientists at the Allen Institute have made a major breakthrough in research for people living with Dravet Syndrome, which is ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.

In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...

Scientists developed a promising gene replacement therapy for Dravet syndrome in mice. The therapy alleviated symptoms ...

In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...

Dravet syndrome is caused by mutations in SCN1A, a gene that produces the sodium channel NaV 1.1. The laboratory has made important progress toward understanding how mutations in this gene cause ...

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...